PHARMA DYNAMICS CLOPIDOGREL 75 mg.
Each tablet contains 75 mg clopidogrel. S3 A42/8.2/0128. NAM NS2 10/7.1/0377. For full prescribing information, refer to the package insert approved by the Medicines Control Council,
Database of Medicine Prices (14 March 2017). Department of Health website.http://www.mpr.gov.za
- Accessed on 30 March 2017.
Current approaches to the prevention of thrombotic
complications in patients with acute coronary syndrome without ST-segment elevation. Topical issues of heart and vascular diseases. 2009;4:4-9. (English translation)
Creager MA. Results of the CAPRIE trial: efficacy and
safety of clopidogrel. Vascular Medicine 1998;3:257-260.
COMMIT Collaborative Group. Addition of clopidogrel to aspirin in 45 852 patients with acute myocardial infarction: randomised placebo-controlled trial. The Lancet
Addition of Clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation. New England Journal of Medicine 2005;352:1179-89.
The CURE Trial
Investigators. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. New England Journal of Medicine 2001;345:494-502.
For further product information contact
P O Box 30958 Tokai Cape Town 7966
021 707 7000
021 701 5898
CUSTOMER CARE LINE
0860 PHARMA (742 762)www.pharmadynamics.co.za
Shown to reduce the risk of atherosclerotic events
in a wide range of patients with a history of:
cost e ective
of atherosclerotic events